Leonard Schleifer
Chief Executive Officer chez REGENERON PHARMACEUTICALS, INC.
Fortune : 2 331 M $ au 31/03/2024
Profil
Fondateur de Regeneron Pharmaceuticals, Inc, Leonard S. Schleifer est coprésident, directeur général et administrateur de cette société. Il était auparavant professeur adjoint au Weill Cornell Medical College. Le Dr Schleifer a obtenu un doctorat de l'université de Virginie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/04/2023 | 1 726 565 ( 82,61% ) | 1 662 M $ | 31/03/2024 | |
| 11/12/2023 | 695 330 ( 0,64% ) | 669 M $ | 31/03/2024 |
Postes actifs de Leonard Schleifer
| Sociétés | Poste | Début |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Chief Executive Officer | 08/01/1988 |
Regeneron Ireland DAC
 Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Chief Executive Officer | 01/01/2013 |
Anciens postes connus de Leonard Schleifer
| Sociétés | Poste | Fin |
|---|---|---|
| Weill Cornell Medical College | Corporate Officer/Principal | - |
Formation de Leonard Schleifer
| University of Virginia | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Health Technology |
